Atropine toxicity caused by erroneous intranasal administration in a pediatric patient: case report
| Autor: | Abdullah Almajed, Mohammad Al-Kadi, Riyadh Alhedaithy, Lama S. Alaula |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Atropine
Male lcsh:Medicine Case Report 030209 endocrinology & metabolism Muscarinic Antagonists Lorazepam 03 medical and health sciences 0302 clinical medicine Atropine sulfate Humans Medication Errors Medicine 030212 general & internal medicine Xylometazoline hydrochloride Administration Intranasal business.industry lcsh:R Imidazoles General Medicine medicine.disease stomatognathic diseases Pediatric patient Child Preschool Anesthesia Toxicity Nasal administration Emergency Service Hospital business Adenoid hypertrophy medicine.drug |
| Zdroj: | Annals of Saudi Medicine, Vol 39, Iss 4, Pp 279-282 (2019) Annals of Saudi Medicine |
| ISSN: | 0975-4466 0256-4947 |
| Popis: | A 28-month-old boy mistakenly received intranasal atropine sulfate instead of Otrivin (xylometazoline hydrochloride) for the treatment of adenoid hypertrophy. Later on, he came to the emergency department with anticholinergic manifestations after the administration of multiple drops. The child presented with a tonic-clonic seizure lasting for a few minutes, followed by a brief loss of consciousness, vomiting, agitation, and irritability, all of which were stabilized by a dose of intravenous lorazepam. Subsequently, he was admitted to the pediatric intensive care unit for observation. Afterwards, he developed agitation and unsteady gait, both of which resolved after receiving neostigmine. Eventually, the child became asymptomatic and was discharged home. To the best of our knowledge, only one similar case has been reported in the literature. SIMILAR CASES PUBLISHED: 1 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|